Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

OmniAb (OABI) Research & Development (2022 - 2025)

OmniAb has reported Research & Development over the past 4 years, most recently at $13.9 million for Q4 2025.

  • Quarterly Research & Development rose 4.53% to $13.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.8 million through Dec 2025, down 13.35% year-over-year, with the annual reading at $47.8 million for FY2025, 13.35% down from the prior year.
  • Research & Development was $13.9 million for Q4 2025 at OmniAb, up from $10.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $14.8 million in Q4 2023 and troughed at $10.4 million in Q3 2025.
  • The 4-year median for Research & Development is $13.3 million (2024), against an average of $13.0 million.
  • Year-over-year, Research & Development increased 27.73% in 2023 and then dropped 22.07% in 2025.
  • A 4-year view of Research & Development shows it stood at $12.9 million in 2022, then rose by 14.3% to $14.8 million in 2023, then decreased by 9.89% to $13.3 million in 2024, then increased by 4.53% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for OABI's Research & Development are $13.9 million (Q4 2025), $10.4 million (Q3 2025), and $10.9 million (Q2 2025).